STEM News Today
SEE OTHER BRANDS

Global take on science and technology news

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on April 23, 2025

Codex Labs Bia Ultra-Hydrating Soothing Lotion Is Awarded Seal of Acceptance from National Eczema Association  and Microbiome-Friendly Certification from MyMicrobiome

Codex Labs Bia Ultra-Hydrating Soothing Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiome

San Jose, CA, USA, April 23, 2025 (GLOBE NEWSWIRE) -- Codex Labs, a Silicon Valley skintech company, announced that its Bia Ultra-Hydrating Soothing Lotion, the European version of its US Bia over-the-counter (OTC) Bia Eczema Relief Lotion has been awarded …

TASSHUB Debuts Market for Creators on Solana, it's 484% up in just 24 Hours After Launch

TASSHUB Debuts Market for Creators on Solana, it's 484% up in just 24 Hours After Launch

HARNDUP, Denmark, April 23, 2025 (GLOBE NEWSWIRE) -- Creator-based Web 3 platform TASSHUB token officially launched on Solana Thursday, with the promise of bridging decentralization to the adult entertainment industry. Now visible on market aggregator …

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025

Five abstracts accepted for poster presentations WARMINSTER, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today …

TomTom provides enhanced navigation to smart’s in-vehicle solutions

TomTom provides enhanced navigation to smart’s in-vehicle solutions

SHANGHAI, April 23, 2025 (GLOBE NEWSWIRE) -- Auto Shanghai – TomTom (TOM2), the location technology specialist, today announced that it has been selected by smart, the premium all-electric intelligent auto brand, to provide enhanced full-stack navigation …

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

VERAXA’s Novel BiTAC Platform has the Potential to Deliver Multiple Next-Generation Solid Tumor Cancer Therapies, Including Novel Antibody-Drug Conjugate ("ADC") and Bispecific T-cell Engager ("TCE") Candidates, with Strong and Differentiated Clinical …

20th China Huabiao Film Awards Ceremony to Be Held in Qingdao on April 27

20th China Huabiao Film Awards Ceremony to Be Held in Qingdao on April 27

QINGDAO, China, April 23, 2025 (GLOBE NEWSWIRE) -- To mark the 120th anniversary of Chinese cinema, the event titled "Building Dreams through Film, Embracing the Spirit of the Era -- The 20th China Huabiao Film Awards Ceremony" will take place in Qingdao, …

Update on Transaction Regulatory Approvals

Update on Transaction Regulatory Approvals

BRISBANE, Australia, April 23, 2025 (GLOBE NEWSWIRE) -- Sayona Mining Limited (“Sayona” or “Company”) (ASX:SYA; OTCQB:SYAXF) provides an update on the proposed transaction with Piedmont Lithium Inc. (“Piedmont Lithium”) (NASDAQ:PLL, ASX:PLL) (see …

Notes-App.AI Launches Smarter Notes AI Platform for Everyday Creativity

Notes-App.AI Launches Smarter Notes AI Platform for Everyday Creativity

New York, April 23, 2025 (GLOBE NEWSWIRE) -- Today, Notes-App.AI officially launched its groundbreaking Notes AI platform, transforming the process of how humans take, manage, and interact with their individual ideas. A next-generation notes app, Notes-App …

Verizon’s 2025 Data Breach Investigations Report: System Intrusions Behind 80% of APAC Breaches

Verizon’s 2025 Data Breach Investigations Report: System Intrusions Behind 80% of APAC Breaches

SINGAPORE, April 23, 2025 (GLOBE NEWSWIRE) -- Verizon Business today released its 2025 Data Breach Investigations Report (DBIR), sounding the alarm on a surge of system intrusions across the Asia-Pacific region. The report reveals that 4 out of 5 data …

Verizon’s 2025 Data Breach Investigations Report: System Intrusion Breaches Double in EMEA

Verizon’s 2025 Data Breach Investigations Report: System Intrusion Breaches Double in EMEA

LONDON, April 23, 2025 (GLOBE NEWSWIRE) -- Verizon Business today released its 2025 Data Breach Investigations Report (DBIR), revealing a dramatic surge in global data breaches, with EMEA experiencing a significant increase in system intrusion breaches. …

CMVC adquiere Orlando Medical Institute y expande su portafolio educativo en el campo de salud con programas de paramédico y atención médica de emergencia

CMVC adquiere Orlando Medical Institute y expande su portafolio educativo en el campo de salud con programas de paramédico y atención médica de emergencia

ORLANDO, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- Compu-Med Vocational Careers (CMVC), anuncia la adquisición de Orlando Medical Institute (OMI). Esta adquisición estratégica acelera la expansión de los programas educativos en salud de CMVC al agregar …

浩鼎将在AACR发表七篇海报论文

浩鼎将在AACR发表七篇海报论文

台北讯, April 23, 2025 (GLOBE NEWSWIRE) -- 浩鼎生技(TPEx: 4174.TWO)今日首次公布其自主开发的次世代GlycOBI®技术平台所开发抗体药物偶联体(ADC)OBI-902的非临床数据,显示其具备优异的药物动力学特性,并在多种具挑战性的实体肿瘤动物模型中展现持续的抗肿瘤活性,且优于目前已上市的TROP2 ADC,显示OBI-902具备成为同类最佳ADC的潜力。OBI-992则为采用半胱氨酸连接技术的TROP2靶向ADC,其耐药性特征异于现有同类产品。 在本次 …

浩鼎將在AACR發表七篇海報論文

浩鼎將在AACR發表七篇海報論文

台北電, April 23, 2025 (GLOBE NEWSWIRE) -- 台灣浩鼎生技(TPEx: 4174. TWO)今首度公布其自主開發的次世代 GlycOBI® 技術平台所開發抗體藥物複合體(ADC)OBI-902 非臨床數據,具有優異的藥物動力學特性,以及在多種具挑戰性的實體腫瘤動物模型中展現持續的抗腫瘤活性,亦證明優於目前已上市的 TROP2 ADC,證明OBI-902 具有成為同類最佳ADC的潛力。OBI-992 為半胱胺酸連接技術的 TROP2 靶向 ADC,其耐藥性特徵有異於目前同類的 …

OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI-992 and OBI-902 Antibody-Drug Conjugates (ADCs), GlycOBI® and ThiOBI® ADC enabling technologies, the OBI-3424 prodrug, and Globo H (GH) science

OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI-992 and OBI-902 Antibody-Drug Conjugates (ADCs), GlycOBI® and ThiOBI® ADC enabling technologies, the OBI-3424 prodrug, and Globo H (GH) science

TAIPEI, Taiwan, April 23, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174. TWO) today announced nonclinical data for OBI-902, a potential best-in-class anti-TROP2 ADC developed using the next generation proprietary GlycOBI® technologies. OBI-902 …

Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025

Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025

Salt Lake City, UT, April 22, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data during the 2025 Digestive Disease Week (DDW) meeting from …

FLNC DEADLINE ALERT: Kirby McInerney LLP Alerts Fluence Energy, Inc. Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit

FLNC DEADLINE ALERT: Kirby McInerney LLP Alerts Fluence Energy, Inc. Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP alerts investors of the imminent May 12, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired Fluence …

SWKS DEADLINE ALERT: Kirby McInerney LLP Alerts Skyworks Solutions, Inc. Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit

SWKS DEADLINE ALERT: Kirby McInerney LLP Alerts Skyworks Solutions, Inc. Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP alerts investors of the imminent May 5, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service